Stereotactic Body Radiation Therapy for less than 3cm (stage I) and 5cm (stage II) inoperable lung tumors: 10 years experience of Montpellier Cancer Institute
CONCLUSION: SBRT is associated with an excellent overall survival and a high rate of local control for less than 3cm (stage I) and 5cm (stage II) lung tumors but a low rate of toxicities. For these patients with many comorbidities, BED over 150Gy seems to be associated with a better loco-regional free survival, while cause of death is often other than lung cancer.PMID:37537027 | DOI:10.1016/j.canrad.2023.05.002
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: A Marguerit D Azria O Riou S Demontoy S Thezenas P Boisselier Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Lung Cancer | Radiation Therapy | Study | Toxicology